Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results
Go back to Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results| (NASDAQ: EPRX) | Delayed: 6.68 -0.68 (9.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.36 | 52 Week High | $ | |||
| Open | $7.38 | 52 Week Low | $ | |||
| Day High | $7.45 | P/E | N/A | |||
| Day Low | $6.67 | EPS | $ | |||
| Volume | 174,229 | |||||
| (NASDAQ: EPRX) | Delayed: 6.68 -0.68 (9.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.36 | 52 Week High | $ | |||
| Open | $7.38 | 52 Week Low | $ | |||
| Day High | $7.45 | P/E | N/A | |||
| Day Low | $6.67 | EPS | $ | |||
| Volume | 174,229 | |||||

